These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8995624)
1. Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. Leippert M; Beck E; Weiland F; Pfaff E J Virol; 1997 Feb; 71(2):1046-51. PubMed ID: 8995624 [TBL] [Abstract][Full Text] [Related]
2. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Mason PW; Rieder E; Baxt B Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909 [TBL] [Abstract][Full Text] [Related]
3. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells. Storey P; Theron J; Maree FF; O'Neill HG Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881 [TBL] [Abstract][Full Text] [Related]
4. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333 [TBL] [Abstract][Full Text] [Related]
5. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection. Leippert M; Pfaff E J Gen Virol; 2001 Jul; 82(Pt 7):1703-1711. PubMed ID: 11413382 [TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. Li P; Lu Z; Bao H; Li D; King DP; Sun P; Bai X; Cao W; Gubbins S; Chen Y; Xie B; Guo J; Yin H; Liu Z BMC Microbiol; 2011 Jun; 11():154. PubMed ID: 21711567 [TBL] [Abstract][Full Text] [Related]
7. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752 [TBL] [Abstract][Full Text] [Related]
8. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro. Liebermann H; Dölling R; Schmidt D; Thalmann G Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122 [TBL] [Abstract][Full Text] [Related]
9. Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. Mateu MG; Valero ML; Andreu D; Domingo E J Biol Chem; 1996 May; 271(22):12814-9. PubMed ID: 8662712 [TBL] [Abstract][Full Text] [Related]
10. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. Gutiérrez-Rivas M; Pulido MR; Baranowski E; Sobrino F; Sáiz M J Gen Virol; 2008 Oct; 89(Pt 10):2531-2539. PubMed ID: 18796722 [TBL] [Abstract][Full Text] [Related]
11. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Martínez MA; Verdaguer N; Mateu MG; Domingo E Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6798-802. PubMed ID: 9192645 [TBL] [Abstract][Full Text] [Related]
12. Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism. Escarmís C; Carrillo EC; Ferrer M; Arriaza JF; Lopez N; Tami C; Verdaguer N; Domingo E; Franze-Fernández MT J Virol; 1998 Dec; 72(12):10171-9. PubMed ID: 9811758 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin. Amadori M; Berneri C; Archetti IL Vaccine; 1994 Feb; 12(2):159-66. PubMed ID: 7511862 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862 [TBL] [Abstract][Full Text] [Related]
16. [Rescue and identification foot-and-mouth disease virus Asia1/JS/China/2005 strain with Arg-Gly-Asp RGD receptor recognition site]. Li P; Bai X; Cao W; Lu Z; Sun P; Yin H; Liu Z Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):943-8. PubMed ID: 19873760 [TBL] [Abstract][Full Text] [Related]
17. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Rieder E; Berinstein A; Baxt B; Kang A; Mason PW Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817 [TBL] [Abstract][Full Text] [Related]
18. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation. Hernández J; Valero ML; Andreu D; Domingo E; Mateu MG J Gen Virol; 1996 Feb; 77 ( Pt 2 )():257-64. PubMed ID: 8627229 [TBL] [Abstract][Full Text] [Related]
19. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. Piccone ME; Rieder E; Mason PW; Grubman MJ J Virol; 1995 Sep; 69(9):5376-82. PubMed ID: 7636982 [TBL] [Abstract][Full Text] [Related]
20. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus. Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]